Cure My Disease

Don't miss your cure!

 Log in / Sign up

New pill vs. injection: which works better for kids with severe eczema?

NCT ID NCT06461897

Disease control Sponsor: AbbVie Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Aug 07, 2026 · Updated 5 times

Summary

This study tests two medicines for children aged 2 to 12 with moderate to severe eczema that isn't controlled by creams. One group gets upadacitinib (a daily pill or liquid), the other gets dupilumab (an injection every 2 or 4 weeks). The goal is to see which better reduces skin redness, itching, and rash. About 675 children worldwide will take part for up to 160 weeks.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
upadacitinib (oral tablet or solution) and dupilumab (injection)
What this could lead to
If successful, this study could show that upadacitinib is a safe and effective daily pill option for controlling moderate to severe eczema in young children, offering an alternative to injections.
What could go wrong
This is an open-label study, so results may be biased. Both drugs are already approved for older patients, but their long-term safety and effectiveness in very young children are still being studied. Side effects are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

About 675 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2024

Expected to finish

Jul 2030

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

2 to 11 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * A minimum weight of 10 kg and weight and height \> 5th percentile for their age according to local standard growth charts at the Baseline Visit. * Atopic Dermatitis (AD), according to Hanifin and Rajka criteria, with onset of symptoms at least 6 months prior to Baseline. * Eczema Area and Severity Index (EASI) score \>= 16; vIGA-AD score \>= 3 (Note: In countries where dupilumab is only approved for severe AD, subjects to be included in the Randomized Cohort should have severe AD \[vIGA-AD = 4\]); \>= 10% Body Surface Area of AD involvement at the Baseline Visit; and Baseline weekly average of daily Worst Itch Scale (WIS) or Worst Scratch/Itch numerical rating scale (WSI-NRS) \>= 4. * Participant must satisfy at least one of the following criteria (Note: More than 1 criterion may apply to an individual participant. All applicable criteria for each individual participant should be reported): * To be included in the Randomized Cohort (Note: Participants must have severe AD \[vIGA-AD = 4\] in countries where dupilumab is approved only for severe AD.): 1. \[For all countries except US\] Documented history of inadequate response or intolerance to TCS and/or TCI OR for whom use of one or more of these topical treatments is medically inadvisable (e.g., high disease burden, Scoring Atopic Dermatitis (SCORAD) \> 50, EASI score \> 21, or vIGA-AD \> 3). 2. For dupilumab-naïve participants: History of inadequate response to a systemic therapy for AD other than dupilumab or oral corticosteroids or for whom the available systemic treatments are otherwise medically inadvisable (e.g., because of important side effects or safety risks). 3. History of inadequate response to 2 or more courses of oral corticosteroid therapy given for \>= 14 days within 6 months prior to Screening or history of oral corticosteroid rebound, defined as recurrence of AD symptoms within 4 months after its discontinuation. 4. For dupilumab-exposed participants: Prior exposure to dupilumab without documented history of inadequate response or intolerance (i.e., discontinuation of dupilumab for a non-medical reason, such as, but not limited to, non-coverage or loss of coverage for the drug by health insurance, or other logistic challenges \[not safety- or efficacy-related\] precluding the participants continued access to dupilumab). * To be included in the Dupi-IR/Dupi-Medically Inadvisable Cohort: * Previous inadequate response or intolerance to dupilumab OR * Dupilumab is medically inadvisable (e.g., allergy to a component of dupilumab, etc.) AND a documented history of inadequate response or intolerance to TCS and/or TCI. Exclusion Criteria: * Current or past history of other active skin diseases (e.g., psoriasis or Netherton syndrome or lupus erythematosus) or skin infections (bacterial, fungal, or viral) requiring systemic treatment within 4 weeks of the Baseline Visit or which would interfere with the appropriate assessment of AD lesions. * Have used topical treatments for AD (except for topical emollient treatments) including but not limited to TCS, TCI, or topical phosphodiesterase type 4 (PDE-4) inhibitors, within 7 days of the Baseline Visit or any the following prohibited concomitant AD treatments within the specified timeframes below prior to the Baseline Visit: * Systemic therapy for AD, including but not limited to corticosteroids, methotrexate, cyclosporine, azathioprine, PDE-4 inhibitors, interferon-γ, and mycophenolate mofetil within 4 weeks; * Dupilumab within 8 weeks; * Targeted biologic treatments (other than dupilumab) within 5 half-lives (if known) or within 12 weeks, whichever is longer; * Phototherapy treatment, laser therapy, tanning booth, or extended sun exposure that could affect disease severity or interfere with disease assessments within 4 weeks. * Known history of retinal detachment, previous cataract surgery, previous significant ocular trauma, or a known congenital ocular abnormality. * For Randomized Cohort: diagnosed active parasitic infection; suspected or high risk of parasitic infection, unless clinical and (if necessary) laboratory assessment have ruled out active infection before randomization.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Atopic dermatitis are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atopic eczema

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Atopic dermatitis

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    131 sites in 24 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • 3A Research - East location /ID# 267622

    RECRUITING

    El Paso, Texas, 79925, United States

  • ALERSA, s.r.o. /ID# 266245

    RECRUITING

    Košice, Košice Region, 040 01, Slovakia

  • AP-HP - Hopital Necker /ID# 255050

    RECRUITING

    Paris, 75015, France

  • Aeroallergy Research Laboratory /ID# 267247

    RECRUITING

    Savannah, Georgia, 31406, United States

  • Allergy Research Canada /ID# 270230

    RECRUITING

    Niagara Falls, Ontario, L2H 1H5, Canada

  • Amsterdam University Medical Center /ID# 265406

    RECRUITING

    Amsterdam, North Holland, 1105 AZ, Netherlands

  • Applied Research Center and Wellness Clinic /ID# 268547

    RECRUITING

    Little Rock, Arkansas, 72205, United States

  • Arke Estudios Clinicos S.A. de C.V. - Veracruz (SMO/Network/Consortium) /ID# 266650

    RECRUITING

    Veracruz, 91910, Mexico

  • Arlington Research Center, Inc /ID# 266330

    RECRUITING

    Arlington, Texas, 76011, United States

  • Azienda Ospedaliero-Universitaria Policlinico Umberto I /ID# 267070

    COMPLETED

    Rome, Roma, 00161, Italy

  • Beijing Children's Hospital /ID# 266350

    RECRUITING

    Beijing, Beijing Municipality, 100045, China

  • British Columbia Children and Women's Hospital and Health Centre /ID# 265395

    RECRUITING

    Vancouver, British Columbia, V6H 3N1, Canada

  • CHU Amiens-Picardie Site Sud /ID# 255083

    RECRUITING

    Amiens, Somme, 80054, France

  • CHU Toulouse - Hopital Larrey /ID# 255048

    RECRUITING

    Toulouse, Haute-Garonne, 31400, France

  • Centre Hospitalier Regional Universitaire de Nancy - Hopitaux de Brabois /ID# 265455

    RECRUITING

    Vandœuvre-lès-Nancy, Meurthe-et-Moselle, 54511, France

  • Centre Hospitalier Universitaire (CHU) Sainte-Justine /ID# 266831

    RECRUITING

    Montreal, Quebec, H3T 1C5, Canada

  • Centre Hospitalier Universitaire de Clermont Ferrand - Hopital Estaing /ID# 267327

    RECRUITING

    Clermont-Ferrand, Puy-de-Dome, 63100, France

  • Centre Hospitalier Universitaire de Nantes - L' Hopital l'hotel-Dieu /ID# 265449

    RECRUITING

    Nantes, Pays de la Loire Region, 44000, France

  • Centre Hospitalier d Argenteuil Victor Dupouy /ID# 265448

    COMPLETED

    Argenteuil, Île-de-France Region, 95107, France

  • Centro De Especialidades Dermatologicas /ID# 267483

    RECRUITING

    Viña del Mar, Valparaiso, 2531169, Chile

  • Centrum Medyczne Angelius Provita /ID# 265456

    RECRUITING

    Katowice, Silesian Voivodeship, 40-615, Poland

  • Centrum Nowoczesnych Terapii Dobry Lekarz sp.z.o.o. /ID# 266030

    RECRUITING

    Krakow, Lesser Poland Voivodeship, 31-011, Poland

  • Charite Universitaetsmedizin Berlin - Campus Mitte /ID# 267411

    RECRUITING

    Berlin, 10117, Germany

  • Chelsea and Westminster Hospital /ID# 266389

    RECRUITING

    London, Greater London, SW10 9NH, United Kingdom

  • Chengdu Women and Children Center Hospital /ID# 266402

    RECRUITING

    Chengdu, Sichuan, 610091, China

  • Children's Hospital Affiliated to Chongqing Medical University /ID# 266876

    RECRUITING

    Yuzhong District, Chongqing Municipality, 400015, China

  • Chu Bordeaux - Hopital Pellegrin /ID# 266818

    RECRUITING

    Bordeaux, New Aquitaine, 33076, France

  • Chungang University Hospital /ID# 266383

    RECRUITING

    Seoul, Seoul Teugbyeolsi, 06973, South Korea

  • Clearlyderm Dermatology - West Boca /ID# 266323

    COMPLETED

    Boca Raton, Florida, 33428, United States

  • Cleaver Medical Group Dermatology /ID# 265099

    COMPLETED

    Dawsonville, Georgia, 30534, United States

  • Clinica Dermacross /ID# 266309

    RECRUITING

    Vitacura, Region Metropolitana Santiago, 7640881, Chile

  • Clinica de Alergia Martti Antila /ID# 266197

    RECRUITING

    Sorocaba, São Paulo, 18040-425, Brazil

  • Clinical Research Group Sp. z o.o. /ID# 266924

    RECRUITING

    Warsaw, Masovian Voivodeship, 01-142, Poland

  • Clinical Research Investigator Group /ID# 268366

    COMPLETED

    Bayamón, 00960, Puerto Rico

  • Conexa Investigacion Clinica /ID# 268728

    RECRUITING

    Buenos Aires, 1012, Argentina

  • Consorci Hospital General Universitario de Valencia /ID# 255289

    RECRUITING

    Valencia, 46014, Spain

  • DOCS Clinical Research - Canal Winchester /ID# 268271

    RECRUITING

    Canal Winchester, Ohio, 43110-2069, United States

  • Dalian Women and Children's Medical Group /ID# 266675

    RECRUITING

    Dalian, Liaoning, 116012, China

  • Dawes Fretzin /ID# 265097

    RECRUITING

    Indianapolis, Indiana, 46256, United States

  • Debreceni Egyetem /ID# 265331

    RECRUITING

    Debrecen, 4032, Hungary

  • DermAssociates - Rockville /ID# 266457

    COMPLETED

    Rockville, Maryland, 20850, United States

  • DermAtelier on Avenue - Toronto /ID# 267850

    COMPLETED

    Toronto, Ontario, M5M 3Z8, Canada

  • DermaMed Research - Oroshaza /ID# 266995

    RECRUITING

    Orosháza, Bekes County, 5900, Hungary

  • Dermatology Research Institute - Blackfoot Trail /ID# 266744

    RECRUITING

    Calgary, Alberta, T2J 7E1, Canada

  • Emory University School Of Medicine - Atlanta /ID# 268832

    RECRUITING

    Atlanta, Georgia, 30322, United States

  • Equity Medical, LLC /ID# 268270

    RECRUITING

    Bowling Green, Kentucky, 42104, United States

  • Erasmus Medisch Centrum /ID# 265408

    RECRUITING

    Rotterdam, South Holland, 3015 CE, Netherlands

  • Eukarya PharmaSite /ID# 265274

    RECRUITING

    Monterrey, Nuevo León, 64718, Mexico

  • Fachklinik Bad Bentheim /ID# 255165

    RECRUITING

    Bad Bentheim, Lower Saxony, 48455, Germany

  • Fakultna nemocnica Trnava /ID# 265245

    COMPLETED

    Trnava, 917 02, Slovakia

  • Fundacion Innovacion Cardiovascular /ID# 266742

    RECRUITING

    Independencia, Santiago Metropolitan, 8380465, Chile

  • HaEmek Medical Center /ID# 266416

    RECRUITING

    Afula, Haifa District, 1834111, Israel

  • Hadassah Medical Center-Hebrew University /ID# 255041

    RECRUITING

    Jerusalem, Jerusalem, 91120, Israel

  • Hallym University Kangnam Sacred Heart Hospital /ID# 267318

    RECRUITING

    Seoul, Seoul Teugbyeolsi, 07441, South Korea

  • Henan Children's Hospital Zhengzhou Children's Hospital /ID# 266832

    RECRUITING

    Zhengzhou, Henan, 450018, China

  • Hospital General Universitario Gregorio Maranon /ID# 255288

    RECRUITING

    Madrid, 28007, Spain

  • Hospital Sant Joan de Deu /ID# 255287

    RECRUITING

    Esplugues de Llobregat, Barcelona, 08950, Spain

  • Hospital Universitario La Paz /ID# 255286

    RECRUITING

    Madrid, 28046, Spain

  • Hospital Universitario Miguel Servet /ID# 255290

    RECRUITING

    Zaragoza, 50009, Spain

  • Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao /ID# 266667

    RECRUITING

    São Paulo, 05403-000, Brazil

  • Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto /ID# 266964

    RECRUITING

    Ribeirão Preto, São Paulo, 14049-900, Brazil

  • Hospital e Maternidade Celso Pierro - PUC-Campinas /ID# 266965

    RECRUITING

    Campinas, São Paulo, 13034-685, Brazil

  • Hunan Children's Hospital /ID# 266365

    RECRUITING

    Changsha, Hunan, 410007, China

  • IRCCS AOU di Bologna Policlinico Sant Orsola Malpighi /ID# 255118

    RECRUITING

    Bologna, 40138, Italy

  • Institute for Skin, Health and Immunity /ID# 266158

    RECRUITING

    Mitcham, Victoria, 3132, Australia

  • Instituto de Neumonologia y Dermatologia /ID# 266146

    RECRUITING

    Buenos Aires, 1425, Argentina

  • Integrative Skin Science and Research /ID# 265108

    RECRUITING

    Sacramento, California, 95815, United States

  • International Clinical Research - Tennessee /ID# 268548

    COMPLETED

    Murfreesboro, Tennessee, 37130, United States

  • Irmandade da Santa Casa de Misericordia de Porto Alegre /ID# 267455

    RECRUITING

    Porto Alegre, Rio Grande do Sul, 90020-090, Brazil

  • Jordan Valley Dermatology & Research Center /ID# 267092

    RECRUITING

    South Jordan, Utah, 84095, United States

  • KK Women's and Children's Hospital /ID# 266519

    RECRUITING

    Singapore, 229899, Singapore

  • Kaohsiung Chang Gung Memorial Hospital /ID# 267791

    RECRUITING

    Kaohsiung City, 833, Taiwan

  • Klinicki Bolnicki Centar Split /ID# 265359

    COMPLETED

    Split, Split-Dalmatia County, 21000, Croatia

  • Klinika Ambroziak Dermatologia /ID# 265458

    RECRUITING

    Warsaw, Masovian Voivodeship, 02-953, Poland

  • Klinika Osipowicz & Turkowski sp.z.o.o /ID# 267490

    RECRUITING

    Warsaw, Masovian Voivodeship, 00-716, Poland

  • Klinika za dječje bolesti Zagreb /ID# 264936

    RECRUITING

    Zagreb, City of Zagreb, 10000, Croatia

  • Konkuk University Medical Center /ID# 264178

    COMPLETED

    Seoul, Seoul Teugbyeolsi, 05030, South Korea

  • Korea University Ansan Hospital /ID# 264169

    RECRUITING

    Ansan-si, Gyeonggido, 15355, South Korea

  • Kunming Childrens Hospital /ID# 266555

    RECRUITING

    Kunming, Yunnan, 650103, China

  • Landeskrankenhaus Salzburg-Universitaetsklinikum der PMU (LKH) /ID# 265427

    RECRUITING

    Salzburg, 5020, Austria

  • Leader Research /ID# 266745

    RECRUITING

    Hamilton, Ontario, L8L 3C3, Canada

  • Linkou Chang Gung Memorial Hospital /ID# 263664

    RECRUITING

    Taoyuan City, 333, Taiwan

  • Lynderm Research Inc /ID# 267006

    RECRUITING

    Markham, Ontario, L3P 1X2, Canada

  • Maritime Dermatology /ID# 267359

    COMPLETED

    Halifax, Nova Scotia, B3K 5R3, Canada

  • Maryland Allergy & Asthma Center /ID# 268032

    RECRUITING

    Lanham, Maryland, 20706, United States

  • Medical Center Cordis /ID# 265250

    COMPLETED

    Pleven, 5800, Bulgaria

  • Medical College Of Wisconsin - Milwaukee Campus /ID# 267236

    RECRUITING

    Milwaukee, Wisconsin, 53226, United States

  • Medical University of South Carolina /ID# 265113

    RECRUITING

    Charleston, South Carolina, 29425, United States

  • Medicover Integrated Clinical Services - Torun (SMO/Network/Consortium) /ID# 265454

    RECRUITING

    Torun, Kuyavian-Pomeranian Voivodeship, 87-100, Poland

  • Medizinische Universitaet Graz /ID# 262741

    RECRUITING

    Graz, Styria, 8010, Austria

  • Medizinische Universitaet Wien /ID# 265417

    RECRUITING

    Vienna, 1090, Austria

  • Monash Health - Monash Medical Centre - Clayton /ID# 267149

    RECRUITING

    Clayton, Victoria, 3168, Australia

  • NZOZ Specjalistyczny Osrodek Dermatologiczny Dermal /ID# 266613

    RECRUITING

    Bialystok, Podlaskie Voivodeship, 15-453, Poland

  • Narodny Ustav Detskych Chorob /ID# 265253

    RECRUITING

    Bratislava, Bratislava Region, 831 01, Slovakia

  • National Taiwan University Hospital /ID# 265510

    RECRUITING

    Taipei, 100, Taiwan

  • National University Hospital /ID# 265685

    RECRUITING

    Singapore, 119074, Singapore

  • Neoclinical Research - Hialeah /ID# 269694

    COMPLETED

    Hialeah, Florida, 33016, United States

  • New Taipei Municipal TuCheng Hospital (Built and Operated by Chang Gung Medical /ID# 266349

    RECRUITING

    New Taipei City, 236, Taiwan

  • Northwestern University Feinberg School of Medicine /ID# 265117

    RECRUITING

    Chicago, Illinois, 60611-2927, United States

  • Oregon Health and Science University /ID# 266483

    RECRUITING

    Portland, Oregon, 97239, United States

  • Ospedale Pediatrico Bambino Gesu /ID# 266118

    RECRUITING

    Rome, Roma, 00165, Italy

  • Pediatric Skin Research - Coral Gables /ID# 266308

    RECRUITING

    Coral Gables, Florida, 33146, United States

  • Penta Hospitals Badania Kliniczne /ID# 265451

    RECRUITING

    Wroclaw, Pomeranian Voivodeship, 54-429, Poland

  • Poliklinika DermaPlus /ID# 265724

    RECRUITING

    Zagreb, City of Zagreb, 10000, Croatia

  • Poliklinika Solmed /ID# 265070

    RECRUITING

    Zagreb, City of Zagreb, 10000, Croatia

  • Prime Clinical Research - Mansfield - East Broad Street /ID# 268042

    RECRUITING

    Mansfield, Texas, 76063, United States

  • Private Practice - Dr. Alma Cruz /ID# 264234

    COMPLETED

    Carolina, 00985, Puerto Rico

  • Progressive Clinical Research - San Antonio /ID# 267262

    RECRUITING

    San Antonio, Texas, 78229, United States

  • Psoriahue - Buenos Aires /ID# 267737

    RECRUITING

    Buenos Aires, 1425, Argentina

  • Queen Elizabeth University Hospital - NHS Greater Glasgow and Clyde /ID# 265219

    RECRUITING

    Glasgow, Lanarkshire, G51 4TF, United Kingdom

  • Rejuvenation Dermatology - Edmonton Downtown /ID# 267871

    RECRUITING

    Edmonton, Alberta, T5J 3S9, Canada

  • Royal Manchester Children'S Hospital /ID# 267693

    RECRUITING

    Manchester, M13 9WL, United Kingdom

  • Royal Victoria Infirmary /ID# 265238

    COMPLETED

    Newcastle upon Tyne, NE1 4LP, United Kingdom

  • Royalderm Agnieszka Nawrocka /ID# 266606

    RECRUITING

    Warsaw, Masovian Voivodeship, 02-962, Poland

  • Sanatorio 9 de Julio /ID# 267678

    RECRUITING

    San Miguel de Tucumán, Tucumán Province, 4000, Argentina

  • Schneider Childrens Medical Center of Israel /ID# 265617

    RECRUITING

    Petah Tikva, Central District, 4920235, Israel

  • Seoul National University Hospital /ID# 264176

    RECRUITING

    Seoul, Seoul Teugbyeolsi, 03080, South Korea

  • Shenzhen Children's Hospital /ID# 266401

    RECRUITING

    Shenzhen, Guangdong, 518026, China

  • Skin Specialists /ID# 266331

    RECRUITING

    Omaha, Nebraska, 68144, United States

  • Sneeze Wheeze & Itch Associates /ID# 267238

    RECRUITING

    Normal, Illinois, 61761, United States

  • Soon Chun Hyang University Hospital Bucheon /ID# 264171

    RECRUITING

    Bucheon-si, Gyeonggido, 14584, South Korea

  • Soroka Medical Center /ID# 265251

    RECRUITING

    Beersheba, Southern District, 8410101, Israel

  • Specialty Hospital Medico /ID# 266116

    RECRUITING

    Rijeka, Primorje-Gorski Kotar County, 51000, Croatia

  • Specjalistyczny Niepubliczny Zaklad Opieki Zdrowotnej Alergologia Plus /ID# 265457

    RECRUITING

    Poznan, Greater Poland Voivodeship, 60-693, Poland

  • St George University Hospitals NHS Foundation Trust /ID# 266984

    RECRUITING

    London, Greater London, SW17 0QT, United Kingdom

  • St Thomas' Hospital - Guy's and St Thomas' NHS Foundation Trust /ID# 265237

    RECRUITING

    London, Greater London, SE1 7EH, United Kingdom

  • Stanford University School of Medicine /ID# 269622

    RECRUITING

    Palo Alto, California, 94304, United States

  • Szegedi Tudomanyegyetem /ID# 265653

    COMPLETED

    Szeged, Csongrád megye, 6720, Hungary

  • Taipei Veterans General Hospital /ID# 265507

    RECRUITING

    Taipei, 112, Taiwan

  • Texas Dermatology and Laser Specialists /ID# 267249

    RECRUITING

    San Antonio, Texas, 78218, United States

  • The 2nd Affiliated Hospital and Yuying Children's Hospital of WMU /ID# 266708

    RECRUITING

    Wenzhou, Zhejiang, 325027, China

  • The Chaim Sheba Medical Center /ID# 265254

    RECRUITING

    Ramat Gan, Tel Aviv, 5265601, Israel

  • The Children's Hospital at Westmead /ID# 265430

    RECRUITING

    Westmead, New South Wales, 2145, Australia

  • Treasure Valley Medical Research /ID# 266838

    RECRUITING

    Boise, Idaho, 83706, United States

  • Triple A Lab Inc /ID# 266615

    RECRUITING

    Hamilton, Ontario, L8S 1G5, Canada

  • UMHAT Alexandrovska EAD /ID# 265256

    COMPLETED

    Sofiya, Sofia, 1431, Bulgaria

  • Unidade Local de Saude Sao Joao /ID# 266111

    RECRUITING

    Porto, 4200-319, Portugal

  • Unidade Local de Saude de Coimbra /ID# 266115

    RECRUITING

    Coimbra, 3000-075, Portugal

  • Unidade Local de Saude de Santo Antonio /ID# 266112

    RECRUITING

    Porto, 4099-003, Portugal

  • Universitaetsklinikum Carl Gustav Carus Dresden /ID# 255167

    RECRUITING

    Dresden, Saxony, 01307, Germany

  • Universitaetsklinikum Erlangen /ID# 255168

    COMPLETED

    Erlangen, Bavaria, 91054, Germany

  • Universitaetsklinikum Muenster /ID# 255166

    RECRUITING

    Münster, North Rhine-Westphalia, 48149, Germany

  • University Hospital Southampton /ID# 266655

    RECRUITING

    Southampton, Hampshire, SO16 6YD, United Kingdom

  • University Hospitals Plymouth NHS Trust /ID# 266980

    RECRUITING

    Plymouth, Devon, PL6 8DH, United Kingdom

  • Univerzitna nemocnica L. Pasteura Kosice /ID# 265239

    RECRUITING

    Košice, Košice Region, 040 01, Slovakia

  • Univerzitna nemocnica Martin /ID# 265947

    RECRUITING

    Martin, Žilina Region, 036 01, Slovakia

  • Washington University School of Medicine - St. Louis /ID# 268545

    RECRUITING

    St Louis, Missouri, 63130, United States

  • West Virginia University Hospitals /ID# 265114

    RECRUITING

    Morgantown, West Virginia, 26506, United States

  • Wright State Physicians Health Center /ID# 268841

    RECRUITING

    Fairborn, Ohio, 45324, United States

  • Xiamen Children's Hospital /ID# 266384

    RECRUITING

    Xiamen, Fujian, 361006, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.